Search Results - Philip Clingan
- Showing 1 - 4 results of 4
-
1
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer by Thomas Hansen, Jonathon Hill, Gary Tincknell, Derrick Siu, Daniel Brungs, Philip Clingan, Lorraine Chantrill, Udit Nindra
Published in Exploration of Targeted Anti-tumor Therapy (2024-09-01)Get full text
Article -
2
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind,... by Michael Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C. Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Published in BMC Cancer (2024-07-01)Get full text
Article -
3
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED) by Thiru Prasanna, Thiru Prasanna, Thiru Prasanna, Laeeq Malik, Laeeq Malik, Robert D. McCuaig, Wen Juan Tu, Fan Wu, Pek Siew Lim, Abel H. Y. Tan, Jane E. Dahlstrom, Jane E. Dahlstrom, Philip Clingan, Eugene Moylan, Jeremy Chrisp, David Fuller, Sudha Rao, Desmond Yip, Desmond Yip
Published in Frontiers in Oncology (2022-06-01)Get full text
Article -
4
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma by Jayesh Desai, Stephane Dalle, Jermaine Coward, Daniel Brungs, Andrew Mant, Margaret McGrath, Andrea Tazbirkova, Piotr Koralewski, Iwona Lugowska, Arunee Dechaphunkul, Virote Sriuranpong, James Oliviero, Philip Clingan, Rahul Ladwa, Eva Muñoz-Couselo, Henri Montaudié, Miguel-Ángel Berciano-Guerrero, Dean Laurence Harris, Susan Arnold, Samuel Fourie, Andriy Kurochkin, Daniel R Malan, Vinay Sharma, Hong Shue, Chaiyut Charoentum, Oleksandr Dudnichenko
Published in Journal for ImmunoTherapy of Cancer (2023-10-01)Get full text
Article
